These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24799886)

  • 21. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
    Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
    J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
    Vrzal R; Doricakova A; Novotna A; Bachleda P; Bitman M; Pavek P; Dvorak Z
    Toxicol Lett; 2011 Feb; 200(3):146-53. PubMed ID: 21115105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives.
    Werling U; Siehler S; Litfin M; Nau H; Göttlicher M
    Mol Pharmacol; 2001 May; 59(5):1269-76. PubMed ID: 11306712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
    Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid.
    Qiao L; Schaack J; Shao J
    Endocrinology; 2006 Feb; 147(2):865-74. PubMed ID: 16282359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study.
    Tang Y; Glauser TA; Gilbert DL; Hershey AD; Privitera MD; Ficker DM; Szaflarski JP; Sharp FR
    Acta Neurol Scand; 2004 Mar; 109(3):159-68. PubMed ID: 14763951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
    Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes.
    Yuyama M; Fujimori K
    Biochem J; 2014 May; 459(3):489-503. PubMed ID: 24511897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk between Epigenetic Modulations in Valproic Acid Deactivated Hepatic Stellate Cells: An Integrated Protein and miRNA Profiling Study.
    Lu P; Yan M; He L; Li J; Ji Y; Ji J
    Int J Biol Sci; 2019; 15(1):93-104. PubMed ID: 30662350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
    Schank JR; Liles LC; Weinshenker D
    Epilepsy Res; 2005 Jun; 65(1-2):23-31. PubMed ID: 15955669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha.
    Juengel E; Bhasin M; Libermann T; Barth S; Michaelis M; Cinatl J; Jones J; Hudak L; Jonas D; Blaheta RA
    World J Urol; 2011 Dec; 29(6):779-86. PubMed ID: 20640575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence.
    Pirozzi C; Lama A; Annunziata C; Cavaliere G; De Caro C; Citraro R; Russo E; Tallarico M; Iannone M; Ferrante MC; Mollica MP; Mattace Raso G; De Sarro G; Calignano A; Meli R
    FASEB J; 2020 Jan; 34(1):676-690. PubMed ID: 31914696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
    Ma L; Wang Y; Chen X; Zhao L; Guo Y
    Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
    Wang JF; Bown C; Young LT
    Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    Löscher W; Fisher JE; Nau H; Hönack D
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1067-78. PubMed ID: 2506334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
    Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
    Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired striatal dopamine output of homozygous Wfs1 mutant mice in response to [K+] challenge.
    Matto V; Terasmaa A; Vasar E; Kõks S
    J Physiol Biochem; 2011 Mar; 67(1):53-60. PubMed ID: 20972658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage.
    Kõks S; Overall RW; Ivask M; Soomets U; Guha M; Vasar E; Fernandes C; Schalkwyk LC
    Physiol Genomics; 2013 Mar; 45(5):182-90. PubMed ID: 23321269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.